Investment firm makes majority equity investment in Demakes
The current leadership will stay on to manage the company.
Stay updated with breaking news from Michael Recht. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The current leadership will stay on to manage the company.
By Deena Beasley (Reuters) - High cost, logistical issues and the prospect of potential treatment advances are holding back adoption of the first gene...
Investment firm TowerBrook Capital Partners has acquired a majority stake in US-based deli meats producer Demakes Enterprises.
High cost, logistical issues and the prospect of potential treatment advances are holding back adoption of the first gene therapies for hemophilia, experts said this week during the American Society...
NEW YORK--(BUSINESS WIRE)--Pathway to Cures (P2C) held its inaugural fund meeting on Saturday, October 28th in Chicago, Illinois. Pathway to Cures, an affiliate of the National Bleeding Disorders Foundation (NBDF), is a venture philanthropy fund focused on investing in early-stage companies developing cures, therapi...